Adipose-Derived Stromal Vascular Fraction/Xenohybrid Bone Scaffold: An Alternative Source for Bone Regeneration

Ilaria Roato, Dimas Carolina Belisario, Mara Compagno, Laura Verderio, Anna Sighinolfi, Federico Mussano, Tullio Genova, Francesca Veneziano, Gianni Pertici, Giuseppe Perale, Riccardo Ferracini

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Adipose tissue-derived stem cells (ASCs) are a promising tool for the treatment of bone diseases or skeletal lesions, thanks to their ability to potentially repair damaged tissue. One of the major limitations of ASCs is represented by the necessity to be isolated and expanded through in vitro culture; thus, a strong interest was generated by the adipose stromal vascular fraction (SVF), the noncultured fraction of ASCs. SVF is a heterogeneous cell population, directly obtained after collagenase treatment of adipose tissue. In order to investigate and compare the bone-regenerative potential of SVF and ASCs, they were plated on SmartBone®, a xenohybrid bone scaffold, already used in clinical practice with successful results. We showed that SVF plated on SmartBone, in the presence of osteogenic factors, had better osteoinductive capabilities than ASCs, in terms of differentiation into bone cells, mineralization, and secretion of soluble factors stimulating osteoblasts. Indeed, we observed an increasing area of new tissue over time, with and without OM. These data strongly support an innovative idea for the use of adipose SVF and bone scaffolds to promote tissue regeneration and repair, also thanks to an easier cell management preparation that allows a potentially larger use in clinical applications.

Original languageEnglish
Article number4126379
JournalStem Cells International
Volume2018
DOIs
Publication statusPublished - Jan 1 2018

Fingerprint

Bone Regeneration
Blood Vessels
Adipose Tissue
Stem Cells
Bone and Bones
Physiologic Calcification
Bone Diseases
Collagenases
Osteoblasts
Regeneration
Population

ASJC Scopus subject areas

  • Molecular Biology
  • Cell Biology

Cite this

Adipose-Derived Stromal Vascular Fraction/Xenohybrid Bone Scaffold : An Alternative Source for Bone Regeneration. / Roato, Ilaria; Belisario, Dimas Carolina; Compagno, Mara; Verderio, Laura; Sighinolfi, Anna; Mussano, Federico; Genova, Tullio; Veneziano, Francesca; Pertici, Gianni; Perale, Giuseppe; Ferracini, Riccardo.

In: Stem Cells International, Vol. 2018, 4126379, 01.01.2018.

Research output: Contribution to journalArticle

Roato, I, Belisario, DC, Compagno, M, Verderio, L, Sighinolfi, A, Mussano, F, Genova, T, Veneziano, F, Pertici, G, Perale, G & Ferracini, R 2018, 'Adipose-Derived Stromal Vascular Fraction/Xenohybrid Bone Scaffold: An Alternative Source for Bone Regeneration', Stem Cells International, vol. 2018, 4126379. https://doi.org/10.1155/2018/4126379
Roato, Ilaria ; Belisario, Dimas Carolina ; Compagno, Mara ; Verderio, Laura ; Sighinolfi, Anna ; Mussano, Federico ; Genova, Tullio ; Veneziano, Francesca ; Pertici, Gianni ; Perale, Giuseppe ; Ferracini, Riccardo. / Adipose-Derived Stromal Vascular Fraction/Xenohybrid Bone Scaffold : An Alternative Source for Bone Regeneration. In: Stem Cells International. 2018 ; Vol. 2018.
@article{e87f933ba2c54c77b63e2d033c6249e0,
title = "Adipose-Derived Stromal Vascular Fraction/Xenohybrid Bone Scaffold: An Alternative Source for Bone Regeneration",
abstract = "Adipose tissue-derived stem cells (ASCs) are a promising tool for the treatment of bone diseases or skeletal lesions, thanks to their ability to potentially repair damaged tissue. One of the major limitations of ASCs is represented by the necessity to be isolated and expanded through in vitro culture; thus, a strong interest was generated by the adipose stromal vascular fraction (SVF), the noncultured fraction of ASCs. SVF is a heterogeneous cell population, directly obtained after collagenase treatment of adipose tissue. In order to investigate and compare the bone-regenerative potential of SVF and ASCs, they were plated on SmartBone{\circledR}, a xenohybrid bone scaffold, already used in clinical practice with successful results. We showed that SVF plated on SmartBone, in the presence of osteogenic factors, had better osteoinductive capabilities than ASCs, in terms of differentiation into bone cells, mineralization, and secretion of soluble factors stimulating osteoblasts. Indeed, we observed an increasing area of new tissue over time, with and without OM. These data strongly support an innovative idea for the use of adipose SVF and bone scaffolds to promote tissue regeneration and repair, also thanks to an easier cell management preparation that allows a potentially larger use in clinical applications.",
author = "Ilaria Roato and Belisario, {Dimas Carolina} and Mara Compagno and Laura Verderio and Anna Sighinolfi and Federico Mussano and Tullio Genova and Francesca Veneziano and Gianni Pertici and Giuseppe Perale and Riccardo Ferracini",
year = "2018",
month = "1",
day = "1",
doi = "10.1155/2018/4126379",
language = "English",
volume = "2018",
journal = "Stem Cells International",
issn = "1687-966X",
publisher = "Hindawi Publishing Corporation",

}

TY - JOUR

T1 - Adipose-Derived Stromal Vascular Fraction/Xenohybrid Bone Scaffold

T2 - An Alternative Source for Bone Regeneration

AU - Roato, Ilaria

AU - Belisario, Dimas Carolina

AU - Compagno, Mara

AU - Verderio, Laura

AU - Sighinolfi, Anna

AU - Mussano, Federico

AU - Genova, Tullio

AU - Veneziano, Francesca

AU - Pertici, Gianni

AU - Perale, Giuseppe

AU - Ferracini, Riccardo

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Adipose tissue-derived stem cells (ASCs) are a promising tool for the treatment of bone diseases or skeletal lesions, thanks to their ability to potentially repair damaged tissue. One of the major limitations of ASCs is represented by the necessity to be isolated and expanded through in vitro culture; thus, a strong interest was generated by the adipose stromal vascular fraction (SVF), the noncultured fraction of ASCs. SVF is a heterogeneous cell population, directly obtained after collagenase treatment of adipose tissue. In order to investigate and compare the bone-regenerative potential of SVF and ASCs, they were plated on SmartBone®, a xenohybrid bone scaffold, already used in clinical practice with successful results. We showed that SVF plated on SmartBone, in the presence of osteogenic factors, had better osteoinductive capabilities than ASCs, in terms of differentiation into bone cells, mineralization, and secretion of soluble factors stimulating osteoblasts. Indeed, we observed an increasing area of new tissue over time, with and without OM. These data strongly support an innovative idea for the use of adipose SVF and bone scaffolds to promote tissue regeneration and repair, also thanks to an easier cell management preparation that allows a potentially larger use in clinical applications.

AB - Adipose tissue-derived stem cells (ASCs) are a promising tool for the treatment of bone diseases or skeletal lesions, thanks to their ability to potentially repair damaged tissue. One of the major limitations of ASCs is represented by the necessity to be isolated and expanded through in vitro culture; thus, a strong interest was generated by the adipose stromal vascular fraction (SVF), the noncultured fraction of ASCs. SVF is a heterogeneous cell population, directly obtained after collagenase treatment of adipose tissue. In order to investigate and compare the bone-regenerative potential of SVF and ASCs, they were plated on SmartBone®, a xenohybrid bone scaffold, already used in clinical practice with successful results. We showed that SVF plated on SmartBone, in the presence of osteogenic factors, had better osteoinductive capabilities than ASCs, in terms of differentiation into bone cells, mineralization, and secretion of soluble factors stimulating osteoblasts. Indeed, we observed an increasing area of new tissue over time, with and without OM. These data strongly support an innovative idea for the use of adipose SVF and bone scaffolds to promote tissue regeneration and repair, also thanks to an easier cell management preparation that allows a potentially larger use in clinical applications.

UR - http://www.scopus.com/inward/record.url?scp=85047054960&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85047054960&partnerID=8YFLogxK

U2 - 10.1155/2018/4126379

DO - 10.1155/2018/4126379

M3 - Article

AN - SCOPUS:85047054960

VL - 2018

JO - Stem Cells International

JF - Stem Cells International

SN - 1687-966X

M1 - 4126379

ER -